Copyright Reports & Markets. All rights reserved.

Global and Japan Pharmaceutical Anti-Counterfeiting Technologie Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pharmaceutical Anti-Counterfeiting Technologie Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Holograms
    • 1.2.3 Colour Shifting Inks
    • 1.2.4 LaserSecure
    • 1.2.5 FluxSecure
    • 1.2.6 DNASecure
    • 1.2.7 BitSecure
    • 1.2.8 Track and Trace Technologies
  • 1.3 Market by Application
    • 1.3.1 Global Pharmaceutical Anti-Counterfeiting Technologie Market Share by Application: 2020 VS 2026
    • 1.3.2 Liquid
    • 1.3.3 Tablet
    • 1.3.4 Capsules
    • 1.3.5 Suppositories
    • 1.3.6 Drops
    • 1.3.7 Inhalers
    • 1.3.8 Injections
    • 1.3.9 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Pharmaceutical Anti-Counterfeiting Technologie Market Perspective (2015-2026)
  • 2.2 Global Pharmaceutical Anti-Counterfeiting Technologie Growth Trends by Regions
    • 2.2.1 Pharmaceutical Anti-Counterfeiting Technologie Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Pharmaceutical Anti-Counterfeiting Technologie Historic Market Share by Regions (2015-2020)
    • 2.2.3 Pharmaceutical Anti-Counterfeiting Technologie Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Pharmaceutical Anti-Counterfeiting Technologie Players by Market Size
    • 3.1.1 Global Top Pharmaceutical Anti-Counterfeiting Technologie Players by Revenue (2015-2020)
    • 3.1.2 Global Pharmaceutical Anti-Counterfeiting Technologie Revenue Market Share by Players (2015-2020)
  • 3.2 Global Pharmaceutical Anti-Counterfeiting Technologie Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Pharmaceutical Anti-Counterfeiting Technologie Revenue
  • 3.4 Global Pharmaceutical Anti-Counterfeiting Technologie Market Concentration Ratio
    • 3.4.1 Global Pharmaceutical Anti-Counterfeiting Technologie Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Anti-Counterfeiting Technologie Revenue in 2019
  • 3.5 Key Players Pharmaceutical Anti-Counterfeiting Technologie Area Served
  • 3.6 Key Players Pharmaceutical Anti-Counterfeiting Technologie Product Solution and Service
  • 3.7 Date of Enter into Pharmaceutical Anti-Counterfeiting Technologie Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Anti-Counterfeiting Technologie Breakdown Data by Type (2015-2026)

  • 4.1 Global Pharmaceutical Anti-Counterfeiting Technologie Historic Market Size by Type (2015-2020)
  • 4.2 Global Pharmaceutical Anti-Counterfeiting Technologie Forecasted Market Size by Type (2021-2026)

5 Pharmaceutical Anti-Counterfeiting Technologie Breakdown Data by Application (2015-2026)

  • 5.1 Global Pharmaceutical Anti-Counterfeiting Technologie Historic Market Size by Application (2015-2020)
  • 5.2 Global Pharmaceutical Anti-Counterfeiting Technologie Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Pharmaceutical Anti-Counterfeiting Technologie Market Size (2015-2026)
  • 6.2 North America Pharmaceutical Anti-Counterfeiting Technologie Market Size by Type (2015-2020)
  • 6.3 North America Pharmaceutical Anti-Counterfeiting Technologie Market Size by Application (2015-2020)
  • 6.4 North America Pharmaceutical Anti-Counterfeiting Technologie Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Pharmaceutical Anti-Counterfeiting Technologie Market Size (2015-2026)
  • 7.2 Europe Pharmaceutical Anti-Counterfeiting Technologie Market Size by Type (2015-2020)
  • 7.3 Europe Pharmaceutical Anti-Counterfeiting Technologie Market Size by Application (2015-2020)
  • 7.4 Europe Pharmaceutical Anti-Counterfeiting Technologie Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Pharmaceutical Anti-Counterfeiting Technologie Market Size (2015-2026)
  • 8.2 China Pharmaceutical Anti-Counterfeiting Technologie Market Size by Type (2015-2020)
  • 8.3 China Pharmaceutical Anti-Counterfeiting Technologie Market Size by Application (2015-2020)
  • 8.4 China Pharmaceutical Anti-Counterfeiting Technologie Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Pharmaceutical Anti-Counterfeiting Technologie Market Size (2015-2026)
  • 9.2 Japan Pharmaceutical Anti-Counterfeiting Technologie Market Size by Type (2015-2020)
  • 9.3 Japan Pharmaceutical Anti-Counterfeiting Technologie Market Size by Application (2015-2020)
  • 9.4 Japan Pharmaceutical Anti-Counterfeiting Technologie Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Pharmaceutical Anti-Counterfeiting Technologie Market Size (2015-2026)
  • 10.2 Southeast Asia Pharmaceutical Anti-Counterfeiting Technologie Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Pharmaceutical Anti-Counterfeiting Technologie Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Pharmaceutical Anti-Counterfeiting Technologie Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 3M Company
    • 11.1.1 3M Company Company Details
    • 11.1.2 3M Company Business Overview
    • 11.1.3 3M Company Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 11.1.4 3M Company Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020))
    • 11.1.5 3M Company Recent Development
  • 11.2 3S Simons Security Systems
    • 11.2.1 3S Simons Security Systems Company Details
    • 11.2.2 3S Simons Security Systems Business Overview
    • 11.2.3 3S Simons Security Systems Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 11.2.4 3S Simons Security Systems Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 11.2.5 3S Simons Security Systems Recent Development
  • 11.3 Alien Technology
    • 11.3.1 Alien Technology Company Details
    • 11.3.2 Alien Technology Business Overview
    • 11.3.3 Alien Technology Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 11.3.4 Alien Technology Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 11.3.5 Alien Technology Recent Development
  • 11.4 Alpvision
    • 11.4.1 Alpvision Company Details
    • 11.4.2 Alpvision Business Overview
    • 11.4.3 Alpvision Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 11.4.4 Alpvision Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 11.4.5 Alpvision Recent Development
  • 11.5 Angstrom Technologies
    • 11.5.1 Angstrom Technologies Company Details
    • 11.5.2 Angstrom Technologies Business Overview
    • 11.5.3 Angstrom Technologies Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 11.5.4 Angstrom Technologies Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 11.5.5 Angstrom Technologies Recent Development
  • 11.6 ThermoFisher Scientific
    • 11.6.1 ThermoFisher Scientific Company Details
    • 11.6.2 ThermoFisher Scientific Business Overview
    • 11.6.3 ThermoFisher Scientific Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 11.6.4 ThermoFisher Scientific Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 11.6.5 ThermoFisher Scientific Recent Development
  • 11.7 Authentix
    • 11.7.1 Authentix Company Details
    • 11.7.2 Authentix Business Overview
    • 11.7.3 Authentix Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 11.7.4 Authentix Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 11.7.5 Authentix Recent Development
  • 11.8 Avery Dennison Corporation
    • 11.8.1 Avery Dennison Corporation Company Details
    • 11.8.2 Avery Dennison Corporation Business Overview
    • 11.8.3 Avery Dennison Corporation Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 11.8.4 Avery Dennison Corporation Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 11.8.5 Avery Dennison Corporation Recent Development
  • 11.9 Colorcon
    • 11.9.1 Colorcon Company Details
    • 11.9.2 Colorcon Business Overview
    • 11.9.3 Colorcon Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 11.9.4 Colorcon Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 11.9.5 Colorcon Recent Development
  • 11.10 Covectra
    • 11.10.1 Covectra Company Details
    • 11.10.2 Covectra Business Overview
    • 11.10.3 Covectra Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 11.10.4 Covectra Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 11.10.5 Covectra Recent Development
  • 11.11 Everest Holovisions
    • 10.11.1 Everest Holovisions Company Details
    • 10.11.2 Everest Holovisions Business Overview
    • 10.11.3 Everest Holovisions Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.11.4 Everest Holovisions Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.11.5 Everest Holovisions Recent Development
  • 11.12 Sanofi
    • 10.12.1 Sanofi Company Details
    • 10.12.2 Sanofi Business Overview
    • 10.12.3 Sanofi Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.12.4 Sanofi Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.12.5 Sanofi Recent Development
  • 11.13 999 Group
    • 10.13.1 999 Group Company Details
    • 10.13.2 999 Group Business Overview
    • 10.13.3 999 Group Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.13.4 999 Group Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.13.5 999 Group Recent Development
  • 11.14 Bayer group
    • 10.14.1 Bayer group Company Details
    • 10.14.2 Bayer group Business Overview
    • 10.14.3 Bayer group Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.14.4 Bayer group Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.14.5 Bayer group Recent Development
  • 11.15 AstraZeneca
    • 10.15.1 AstraZeneca Company Details
    • 10.15.2 AstraZeneca Business Overview
    • 10.15.3 AstraZeneca Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.15.4 AstraZeneca Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.15.5 AstraZeneca Recent Development
  • 11.16 Ball Packaging
    • 10.16.1 Ball Packaging Company Details
    • 10.16.2 Ball Packaging Business Overview
    • 10.16.3 Ball Packaging Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.16.4 Ball Packaging Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.16.5 Ball Packaging Recent Development
  • 11.17 ACG-Worldwide
    • 10.17.1 ACG-Worldwide Company Details
    • 10.17.2 ACG-Worldwide Business Overview
    • 10.17.3 ACG-Worldwide Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.17.4 ACG-Worldwide Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.17.5 ACG-Worldwide Recent Development
  • 11.18 Acsis
    • 10.18.1 Acsis Company Details
    • 10.18.2 Acsis Business Overview
    • 10.18.3 Acsis Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.18.4 Acsis Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.18.5 Acsis Recent Development
  • 11.19 Alliance for Safe Online Pharmacies
    • 10.19.1 Alliance for Safe Online Pharmacies Company Details
    • 10.19.2 Alliance for Safe Online Pharmacies Business Overview
    • 10.19.3 Alliance for Safe Online Pharmacies Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.19.4 Alliance for Safe Online Pharmacies Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.19.5 Alliance for Safe Online Pharmacies Recent Development
  • 11.20 Amcor
    • 10.20.1 Amcor Company Details
    • 10.20.2 Amcor Business Overview
    • 10.20.3 Amcor Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.20.4 Amcor Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.20.5 Amcor Recent Development
  • 11.21 Atlantic Zeiser
    • 10.21.1 Atlantic Zeiser Company Details
    • 10.21.2 Atlantic Zeiser Business Overview
    • 10.21.3 Atlantic Zeiser Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.21.4 Atlantic Zeiser Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.21.5 Atlantic Zeiser Recent Development
  • 11.22 Amgen
    • 10.22.1 Amgen Company Details
    • 10.22.2 Amgen Business Overview
    • 10.22.3 Amgen Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.22.4 Amgen Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.22.5 Amgen Recent Development
  • 11.23 Alcan Packaging
    • 10.23.1 Alcan Packaging Company Details
    • 10.23.2 Alcan Packaging Business Overview
    • 10.23.3 Alcan Packaging Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.23.4 Alcan Packaging Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.23.5 Alcan Packaging Recent Development
  • 11.24 AlpVision
    • 10.24.1 AlpVision Company Details
    • 10.24.2 AlpVision Business Overview
    • 10.24.3 AlpVision Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.24.4 AlpVision Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.24.5 AlpVision Recent Development
  • 11.25 Axway
    • 10.25.1 Axway Company Details
    • 10.25.2 Axway Business Overview
    • 10.25.3 Axway Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.25.4 Axway Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.25.5 Axway Recent Development
  • 11.26 Applied DNA Sciences
    • 10.26.1 Applied DNA Sciences Company Details
    • 10.26.2 Applied DNA Sciences Business Overview
    • 10.26.3 Applied DNA Sciences Pharmaceutical Anti-Counterfeiting Technologie Introduction
    • 10.26.4 Applied DNA Sciences Revenue in Pharmaceutical Anti-Counterfeiting Technologie Business (2015-2020)
    • 10.26.5 Applied DNA Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Pharmaceutical Anti-Counterfeiting Technologie Scope and Market Size
    Pharmaceutical Anti-Counterfeiting Technologie market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Anti-Counterfeiting Technologie market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Holograms
    Colour Shifting Inks
    LaserSecure
    FluxSecure
    DNASecure
    BitSecure
    Track and Trace Technologies

    Market segment by Application, split into
    Liquid
    Tablet
    Capsules
    Suppositories
    Drops
    Inhalers
    Injections
    Others

    Based on regional and country-level analysis, the Pharmaceutical Anti-Counterfeiting Technologie market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Pharmaceutical Anti-Counterfeiting Technologie market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    3M Company
    3S Simons Security Systems
    Alien Technology
    Alpvision
    Angstrom Technologies
    ThermoFisher Scientific
    Authentix
    Avery Dennison Corporation
    Colorcon
    Covectra
    Everest Holovisions
    Sanofi
    999 Group
    Bayer group
    AstraZeneca
    Ball Packaging
    ACG-Worldwide
    Acsis
    Alliance for Safe Online Pharmacies
    Amcor
    Atlantic Zeiser
    Amgen
    Alcan Packaging
    AlpVision
    Axway
    Applied DNA Sciences

    Buy now